ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Ibogaine Clinic Inc Unveils Details on Landmark Approach to Addiction Treatment through Dopamine Regulation

Playa del Carmen, Mexico (Newsworthy.ai) Wednesday Dec 27, 2023 @ 7:00 AM Eastern —

Ibogaine Clinic Inc, a pioneer in addiction treatment, has announced its cutting-edge approach to combating addiction by harnessing the unique properties of ibogaine, a natural occurring psychoactive substance, to regulate dopamine receptors, offering new hope for individuals struggling with addiction, depression, anxiety, and PTSD.

“After so many years successfully adapting our protocols to each individual's specific needs, we’ve had no shortage inquiries about the neurological functions on how we achieve it,” says facility founder Rabbi David Dardashti. “Ibogaine’s function on regulating dopamine receptors is one massive piece of the puzzle, which we incorporate with a wealth of other tools to achieve the desired healing result.”

Restoring Balance in the Brain

Ibogaine, derived from the roots of the iboga plant, is renowned for its ability to restore and modulate dopamine receptors in the brain. This psychoactive alkaloid increases levels of GABA (gamma-aminobutyric acid), inducing a calming effect on the brain. This mechanism significantly reduces cravings and withdrawal symptoms, common challenges in overcoming drug addiction.

Addressing the Root Cause of Addiction

Addictive substances alter the brain's dopamine system, responsible for pleasure, motivation, and movement, leading to tolerance and dependence. Ibogaine's interaction with various neurotransmitter systems, particularly the dopamine system, is critical. By inhibiting monoamine oxidase (MAO) activity, ibogaine increases dopamine availability, counteracting the harmful effects of chronic drug use on the brain's reward system.

A key aspect of Ibogaine Clinic Inc's approach is the activation of the D3 dopamine receptor, a crucial element in addiction development and relapse. Activation of this receptor has demonstrated reduced drug-seeking behavior in animal models, highlighting its potential in human treatments.

Promoting Neuroplasticity for Lasting Change

Beyond its immediate effects in helping the subject access and process their traumas, ibogaine promotes neuroplasticity – the brain's ability to adapt and change. This is vital in reversing the long-term changes caused by addictive drugs and restoring normal functionality to the dopamine system.

Ibogaine by David Dardashti’s innovative use of ibogaine represents a significant advancement in addiction therapy, and is continuing to foster in the future of the ibogaine movement. The natural substance’s ability to regulate dopamine and promote brain healing offers a promising path for those seeking an effective treatment for addiction and related disorders, but only when used under strict protocols by individuals with an impeccable track record of working with the substance, and under medical supervision.

For those who wish to learn more specifics about our protocols, or inquire about treatment, please call 1-800-818-4511.

This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform.™

The reference URL for this press release is located here Ibogaine Clinic Inc Unveils Details on Landmark Approach to Addiction Treatment through Dopamine Regulation.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.